2
Participants
Start Date
May 31, 2010
Primary Completion Date
July 31, 2011
Study Completion Date
December 31, 2011
ACT-385781A (Actelion Epoprostenol)
per Prescribing Information
Flolan®
per Prescribing Information
University of Pennsylvania-Penn Presybyterian Medical Center, Philadelphia
Duke University Medical Center, Durham
Vanderbilt Medical Center, Nashville
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
University of Colorado - Denver, Aurora
University of California - San Diego, La Jolla
Lead Sponsor
Actelion
INDUSTRY